Sylvia Nghiem-Buffet

TL;DR: The present results indicate that pseudocysts are frequently seen on OCT in eyes with atrophic AMD and their presence should not be considered as a manifestation of neovascular AMD that requires prompt treatment.

TL;DR: The combined findings of conventional imaging and OCTA demonstrate distinctive features of inflammatory lesions and CNV in multifocal choroiditis, allowing an appropriate management of these sight-threatening lesions, however, OCTA alone did not distinguish between active and inactive CNVs and should be integrated into an MMI approach.

TL;DR: The real-life efficacy of ranibizumab in DME at M12 and the need for a large number of injections to achieve better visual outcomes are confirmed.

TL;DR: It is confirmed that perifoveal exudative vascular anomalous complex corresponds to a new entity that differs from other conditions associated with capillary aneurysmal lesions and visual improvement could be obtained after treatment with focal laser or intravitreal anti-vascular endothelial growth factor agents.

TL;DR: In 2010, monotherapy with ranibizumab for exudative AMD achieved better visual results than in 2007 in the clinical setting, despite the treatment of older patients with better baseline VA.